author-photo

Doran Ksienski

University of British Columbia

4

Papers

19

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Survival Outcomes Following Discontinuation of Ipilimumab and Nivolumab for Advanced Melanoma in a Population-based Cohort.

2021 Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Immune related adverse events and treatment discontinuation in patients older and younger than 75 years with advanced melanoma receiving nivolumab or pembrolizumab.

2021 Journal of Geriatric Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Association of age with differences in immune related adverse events and survival of patients with advanced nonsmall cell lung cancer receiving pembrolizumab or nivolumab

2020 Journal of Geriatric Oncology
Show All
- Source
- Cite
- Save
Citations (9)
Chest Pain and Cough in a 33-Year-Old Postpartum Woman

2007 Chest
Show All
- Source
- Cite
- Save
Citations (10)